This website uses cookies to ensure you get the best experience.

This website uses 
cookies
 to ensure you
get the best experience.

Accept cookies

Accept cookies

Biography

Kyle Barbato

Interim Head of Talent Acquisition

Biography

Darcell Mckenzie

Executive Assistant

Darcell is a skilled executive assistant with a strong background in supporting senior leadership. With over 15 years of experience, Darcell specializes in managing schedules, coordinating projects, and ensuring the smooth operation of executive workflows. At 1910, Darcell serves as a reliable and proactive partner to the Founder & CEO, helping to streamline communication and maintain organizational efficiency. Darcell is passionate about supporting the success of both the CEO and the broader organization.

Biography

Daniel Ramirez

Data Engineering Fellow

Biography

Matt McCoy, PhD

AI Research Fellow

Matt has a PhD in Computational Biology and Bioinformatics from George Mason University, where he developed methods to utilize protein structure dynamics to predict the phenotypic result of genomic mutations. He has continued to gain experience integrating AI into bioinformatic and protein structure analysis across a number of biotech applications (microbial characterization, agriculture, healthcare, drug development). At 1910, he contributes to the development of the ROSALYND platform.

Biography

Juan Yancovich

Software Engineering Fellow

Biography

Sidharth Shankar

Research Associate II, Biology

At 1910, Sidharth works on all aspects of our biological automation platform, which leverages state-of-the-art robotics to automate assay development, validation, and scale up for high throughput screening of therapeutics designed by our AI-powered ELVIS™ and ROSALYND™ platforms. Sidharth received his bachelor’s in Microbiology from the University of Washington, and spent three years in the Otterbein Lab at Harvard Medical School where he investigated the therapeutic potential of low dose carbon monoxide across models of sepsis and traumatic brain injury.

Biography

Nick Sciuto

BD Operations & Talent Acquisition

Nick plays a key role in managing full-lifecycle recruitment efforts across the organization. With over seven years of experience in talent acquisition, particularly within high-growth biotechnology companies, he leverages his industry expertise to effectively meet hiring needs and support the company’s ongoing growth and success.

Biography

Ify Orakwue, CPA, MBA, MST

Director of Finance & Accounting

Ify leads the finance and accounting function at 1910, managing day-to-day operations and building scalable financial systems to support growth. A results-oriented CPA, Ify has over a decade of experience in biotech startups. Before joining 1910, Ify was the Director of Finance at Caraway Therapeutics, acquired by Merck & Co., and the Controller at Hydra Biosciences, which sold its lead pain asset to Eli Lilly. Ify holds an active CPA license and has an MBA and MS in Taxation from Suffolk University.

Biography

Yujun Tao, PhD

Computational Theoretical Chemist I

Biography

Francis Acquah, PhD

Associate Scientist, Biology

At 1910, Francis works on developing optimized workflows for our biological automation platform that leverages state-of-the-art robotics and software to automate assay development, validation and high-throughput data analysis to support clear decision-making. Francis received his PhD from the University of Oklahoma Health Science Center, Department of Biochemistry where he used integrated computational, biochemical and crystallographic approaches to identify druglike compounds targeting nicotinic receptor and RNA double helices.

Biography

Sebastian Martinez, PhD

AI Research Scientist I

Biography

Lakshmi Chivukula, PhD

Associate Scientist, Biology

Lakshmi received her Ph.D. in Nanoscience at University of North Carolina Greensboro, where she studied the Interaction mechanism of pathogenic yeast with nanostructured surfaces thereby investigating how such interaction influences the sterol quantity and antifungal drug resistance of pathogenic yeast. At 1910, Lakshmi works on developing and validating biochemical and cell-based high throughput screening assays for therapeutics designed by our AI-powered ELVIS™ and ROSALYND™ platforms.

Biography

Matthew Sherman

Automation Engineer III

Matt studied biomedical engineering at Stevens Institute of Technology where he earned his bachelor's degree.  He spent the last 7 years working in lab automation and compound management for oncology discovery.  At 1910, Matt works on implementing and optimizing automated processes for our biological assays and inventory.

Biography

Leerang Yang, PhD

AI Research Scientist I

Biography

Mostafa Abedi, PhD

Computational Theoretical Chemist I

Mostafa received his Ph.D. from Technical University of Denmark in computational and theoretical Chemistry. He spent several years working as a postdoctoral researcher at Brown University to leverage the power of machine learning techniques to develop efficient and accurate high-dimensional potential energy surfaces. At 1910, his work involves utilizing computational chemistry tools to study and design small and large drug molecules with ELVIS™ and ROSALYND™ platforms.

Biography

Cole Baker, MEng

AI Research Scientist I

Cole studied computer science at MIT where he earned his bachelor’s degree and his M.Eng. while researching at the Pantazis Magnetoencephalography LAB. His work combined machine learning, brain imaging and hyperbolic geometry to identify the first signs of Alzheimer’s Disease and the potential for cognitive trainings to mitigate disease progression. At 1910, he works with ELVIS™ and ROSALYND™ platforms to improve training efficiency, maximize model performance, and implement state of the art research.

Biography

Reyal Hoxie, PhD

Scientist I, Biology

Reyal received her Ph.D. in Biochemistry and Biophysics at Brandeis University, where she investigated the energetics of binding for Hsp90 inhibitors and how Hsp90 inhibitors alter the effect of BiP on the conformation of Grp94. At 1910, Reyal works on all aspects of our biological automation platform, leveraging state-of-the-art robotics to automate assay development, validation, and scale up for high throughput screening of therapeutics designed by our AI-powered ELVIS™ and ROSALYND™ platforms.

Biography

Brett Spurrier, PhD

EIR, AI for Biologics R&D

Biography

Jesse W. Collins, PhD

AI Research Scientist III

Jesse studied physics at MIT, and earned his Ph.D. from Harvard University, partly supported by an NSF IGERT fellowship in Biomechanics. He was a postdoc on an NIH-funded project in neuron activity recording. He trained AI models for genetics and tissue architecture studies before joining 1910 as an AI Research Fellow on the CANDID™ platform for small molecule discovery.

Biography

Liping Wu, PhD

Associate Director of Biology

Liping received her PhD in cell and molecular biology from the Australian National University. At 1910 Genetics, she manages R&D operations and thrives on assay biology innovations for the ROSALYND TM platforms. Before joining 1910, Liping served as deputy head of R&D at Prestige Biopharmaceuticals USA. Prior to that, she worked at Cell Assay Innovations, Millennium Pharmaceuticals, and Maxthera Pharmaceuticals.

Biography

Zhinan Xia, PhD

EIR, Biologics R&D

Biography

Brandon Moore, PhD

Head of Artificial Intelligence Research & Machine Learning Engineering

Brandon harnesses machine learning and parallel computing to design small molecule therapeutics using our AI-powered E​LVIS​™ and ROSALYND​™ platforms.​ He received his Bachelor’s degree in Cognitive Neuroscience from MIT and a Ph.D. in Neuroscience from Vanderbilt where he leveraged neural networks to study the primate visual system. Once a King of the Nerds contestant, Brandon enjoys creative STEM projects like building animatronic chatbots, training generative art algorithms, and teaching monkeys addition (PNAS/I Fing Love Science).

Biography

Jonathan O'Connell, PhD

Chief Technology Officer

Biography

Random Guy

Biography

Suresh Poda, PhD

VP of Neuroscience & Preclinical Research, Encoded Therapeutics

Scientific Advisory Board

Suresh is the Vice President of Neuroscience and Preclinical Research at Encoded Therapeutics, a pioneering gene therapy company focusing on neurological diseases. Before joining Encoded, Dr. Suresh held senior research positions at Eisai, Denali, Lundbeck, and started his industry career at AstraZeneca, following a decade of academic research at the University of Michigan and the University of Montreal. He has led numerous drug development programs from discovery through the early clinical stage, focusing on therapies for psychiatry, neurology, and inflammatory diseases.

Biography

Ashish Vaswani, PhD

CEO, Essential AI

Technology Advisory Board

Biography

Ted Love, MD

Former CEO, Global Blood Therapeutics

Business Advisory Board

Biography

Cecil Lynch

Global Biomedical Informatics Lead, Accenture

Technology Advisory Board

Biography

Tom Lounibos

Global Managing Director, Accenture Ventures

Business Advisory Board

Biography

Kailash Swarna, MBA

Managing Director of Life Sciences, Accenture

Technology Advisory Board

Biography

Ray Pressburger

Senior Managing Director & Head of Life Sciences Strategy, Accenture

Business Advisory Board

Biography

Sam Altman

CEO, OpenAI

Technology Advisory Board

Biography

George Golumbeski, PhD

Partner, DROIA Ventures

Chairman - Business Advisory Board

Trained as a research scientist, George has focused on enabling young, innovation-driven companies to bring breakthrough medications into medical practice. In his more than 25 years leading Business Development organizations, he has contributed to advancement of numerous marketed medications that are benefiting patients worldwide. Known globally for his interest in leading-edge science and his creativity in forging inter-company collaborations, he was recognized in 2014 by Fierce Biotech as one of the 20 most influential people in the Biotechnology industry.

Biography

Shaan Gandhi, MD, DPhil

VP of Strategic Partnerships, Pfizer

Independent Board Director

Biography

Old Kyle Barbato

Interim Head of Talent Acquisition

Biography

Old Darcell Mckenzie

Executive Assistant to the CEO

Darcell is a skilled executive assistant with a strong background in supporting senior leadership. With over 15 years of experience, Darcell specializes in managing schedules, coordinating projects, and ensuring the smooth operation of executive workflows. At 1910, Darcell serves as a reliable and proactive partner to the Founder & CEO, helping to streamline communication and maintain organizational efficiency. Darcell is passionate about supporting the success of both the CEO and the broader organization.

Biography

Old Nick Sciuto

BD Operations & Talent Acquisition

Nick plays a key role in managing full-lifecycle recruitment efforts across the organization. With over seven years of experience in talent acquisition, particularly within high-growth biotechnology companies, he leverages his industry expertise to effectively meet hiring needs and support the company’s ongoing growth and success.

Biography

Old Matt McCoy

AI Research Fellow

Matt has a PhD in Computational Biology and Bioinformatics from George Mason University, where he developed methods to utilize protein structure dynamics to predict the phenotypic result of genomic mutations. He has continued to gain experience integrating AI into bioinformatic and protein structure analysis across a number of biotech applications (microbial characterization, agriculture, healthcare, drug development). At 1910, he contributes to the development of the ROSALYND platform.

Biography

Old Daniel Ramirez

Data Engineering Fellow

Biography

Old Juan Yancovich

Software Engineering Fellow

Biography

Old Ify Orakwue, CPA, MBA, MST

Director of Finance & Accounting

Ify leads the finance and accounting function at 1910, managing day-to-day operations and building scalable financial systems to support growth. A results-oriented CPA, Ify has over a decade of experience in biotech startups. Before joining 1910, Ify was the Director of Finance at Caraway Therapeutics, acquired by Merck & Co., and the Controller at Hydra Biosciences, which sold its lead pain asset to Eli Lilly. Ify holds an active CPA license and has an MBA and MS in Taxation from Suffolk University.

Biography

Old Sidharth Shankar

Research Associate II, Biology

At 1910, Sidharth works on all aspects of our biological automation platform, which leverages state-of-the-art robotics to automate assay development, validation, and scale up for high throughput screening of therapeutics designed by our AI-powered ELVIS™ and ROSALYND™ platforms. Sidharth received his bachelor’s in Microbiology from the University of Washington, and spent three years in the Otterbein Lab at Harvard Medical School where he investigated the therapeutic potential of low dose carbon monoxide across models of sepsis and traumatic brain injury.

Biography

Old Yujun Tao, Ph.D.

Computational Theoretical Chemist I

Biography

Old Matthew Sherman

Automation Engineer III

Matt studied biomedical engineering at Stevens Institute of Technology where he earned his bachelor's degree.  He spent the last 7 years working in lab automation and compound management for oncology discovery.  At 1910, Matt works on implementing and optimizing automated processes for our biological assays and inventory.

Biography

Old Lakshmi Chivukula, Ph.D.

Associate Scientist, Biology

Lakshmi received her Ph.D. in Nanoscience at University of North Carolina Greensboro, where she studied the Interaction mechanism of pathogenic yeast with nanostructured surfaces thereby investigating how such interaction influences the sterol quantity and antifungal drug resistance of pathogenic yeast. At 1910, Lakshmi works on developing and validating biochemical and cell-based high throughput screening assays for therapeutics designed by our AI-powered ELVIS™ and ROSALYND™ platforms.

Biography

Old Francis Acquah, PhD

Associate Scientist, Biology

At 1910, Francis works on developing optimized workflows for our biological automation platform that leverages state-of-the-art robotics and software to automate assay development, validation and high-throughput data analysis to support clear decision-making. Francis received his PhD from the University of Oklahoma Health Science Center, Department of Biochemistry where he used integrated computational, biochemical and crystallographic approaches to identify druglike compounds targeting nicotinic receptor and RNA double helices.

Biography

Old Reyal Hoxie, Ph.D.

Scientist I Biology

Reyal received her Ph.D. in Biochemistry and Biophysics at Brandeis University, where she investigated the energetics of binding for Hsp90 inhibitors and how Hsp90 inhibitors alter the effect of BiP on the conformation of Grp94. At 1910, Reyal works on all aspects of our biological automation platform, leveraging state-of-the-art robotics to automate assay development, validation, and scale up for high throughput screening of therapeutics designed by our AI-powered ELVIS™ and ROSALYND™ platforms.

Biography

Old Cole Baker, M.Eng.

AI Research Scientist I

Cole studied computer science at MIT where he earned his bachelor’s degree and his M.Eng. while researching at the Pantazis Magnetoencephalography LAB. His work combined machine learning, brain imaging and hyperbolic geometry to identify the first signs of Alzheimer’s Disease and the potential for cognitive trainings to mitigate disease progression. At 1910, he works with ELVIS™ and ROSALYND™ platforms to improve training efficiency, maximize model performance, and implement state of the art research.

Biography

Old Mostafa Abedi, PhD

Computational Theoretical Chemist I

Mostafa received his Ph.D. from Technical University of Denmark in computational and theoretical Chemistry. He spent several years working as a postdoctoral researcher at Brown University to leverage the power of machine learning techniques to develop efficient and accurate high-dimensional potential energy surfaces. At 1910, his work involves utilizing computational chemistry tools to study and design small and large drug molecules with ELVIS™ and ROSALYND™ platforms.

Biography

Old Jesse W. Collins, PhD

AI Research Scientist III

Jesse studied physics at MIT, and earned his Ph.D. from Harvard University, partly supported by an NSF IGERT fellowship in Biomechanics. He was a postdoc on an NIH-funded project in neuron activity recording. He trained AI models for genetics and tissue architecture studies before joining 1910 as an AI Research Fellow on the CANDID™ platform for small molecule discovery.

Biography

Old LipIng Wu, PhD

Associate Director of Biology

Liping received her PhD in cell and molecular biology from the Australian National University. At 1910 Genetics, she manages R&D operations and thrives on assay biology innovations for the ROSALYND TM platforms. Before joining 1910, Liping served as deputy head of R&D at Prestige Biopharmaceuticals USA. Prior to that, she worked at Cell Assay Innovations, Millennium Pharmaceuticals, and Maxthera Pharmaceuticals.

Biography

Old Brandon Moore, Ph.D.

Head of Artificial Intelligence Research & Machine Learning Engineering

Brandon harnesses machine learning and parallel computing to design small molecule therapeutics using our AI-powered E​LVIS​™ and ROSALYND​™ platforms.​ He received his Bachelor’s degree in Cognitive Neuroscience from MIT and a Ph.D. in Neuroscience from Vanderbilt where he leveraged neural networks to study the primate visual system. Once a King of the Nerds contestant, Brandon enjoys creative STEM projects like building animatronic chatbots, training generative art algorithms, and teaching monkeys addition (PNAS/I Fing Love Science).

Biography

Jen Asher, PhD

Founder & CEO

Board Director

Before founding 1910, Jen worked at the intersection of life science, technology, and business. Prior roles include Management Consultant at Bain & Company, Director of Business Development at a health-tech startup (pre-seed to Series A), and drug discovery stints at Novartis and Eli Lilly. During her Ph.D. research, Jen was an HHMI Predoctoral Fellow at the medical schools of Tufts University and Harvard University.

By achieving our mission to Make Every Pharma Company an AI Company™, we will realize our bold and ambitious vision to Make Undruggable Targets a Thing of the Past™, curing diseases once thought untreatable, and bringing new hope to patients.

Jen Asher, Ph.D.

Founder & CEO, 1910

Founder Video

2:13

Meet the Team

Jen Asher, PhD

Founder & CEO

Brandon Moore, PhD

Head of Artificial Intelligence Research & Machine Learning Engineering

Zhinan Xia, PhD

EIR, Biologics R&D

Liping Wu, PhD

Associate Director of Biology

Jesse W. Collins, PhD

AI Research Scientist III

Brett Spurrier, PhD

EIR, AI for Biologics R&D

Reyal Hoxie, PhD

Scientist I, Biology

Cole Baker, MEng

AI Research Scientist I

Mostafa Abedi, PhD

Computational Theoretical Chemist I

Leerang Yang, PhD

AI Research Scientist I

Matthew Sherman

Automation Engineer III

Lakshmi Chivukula, PhD

Associate Scientist, Biology

Sebastian Martinez, PhD

AI Research Scientist I

Francis Acquah, PhD

Associate Scientist, Biology

Yujun Tao, PhD

Computational Theoretical Chemist I

Ify Orakwue, CPA, MBA, MST

Director of Finance & Accounting

Nick Sciuto

BD Operations & Talent Acquisition

Sidharth Shankar

Research Associate II, Biology

Matt McCoy, PhD

AI Research Fellow

Darcell Mckenzie

Executive Assistant

Nothing excites me more than witnessing the wet lab validation of our algorithms and therapeutic designs, whether in a dish, in a mouse, or beyond!  I love that this community provides the environment to foster real AI-driven impact that we can actually see in biological assays.

Brandon Moore, PhD

Head of Artificial Intelligence Research & Machine Learning Engineering

Every day working at 1910 is rewarding — I get to work alongside people who are caring, open-minded, passionate, creative, and collaborative. Together, we challenge assumptions, push the boundaries of science and the state-of-art-technologies, and thrive to make “undruggable” a thing of the past through our unique and powerful ITO™ platform that integrates AI, biological automation, and computation.

Liping Wu, PhD

Associate Director of Biology

After years of training, I thought at some point I'd primarily apply my skills instead of needing to learn new things routinely. At 1910, it became clear to me that not only do I expect to continuously learn new things and apply them, to understand diseases and discover therapeutics, but that this constant cycle of learning and application is how I'd prefer my career to unfold. My growth with 1910 has been in depth in my area of AI Research, and in breadth via collaborations in medicinal chemistry, computational chemistry, biology, and across our business and industry more broadly.

Jesse W. Collins, PhD

AI Research Scientist III

Board of Directors and Advisors

Jen Asher, PhD

Founder & CEO

Board Director

Shaan Gandhi, MD, DPhil

VP of Strategic Partnerships, Pfizer

Independent Board Director

George Golumbeski, PhD

Partner, DROIA Ventures

Chairman - Business Advisory Board

Sam Altman

CEO, OpenAI

Technology Advisory Board

Ray Pressburger

Senior Managing Director & Head of Life Sciences Strategy, Accenture

Business Advisory Board

Kailash Swarna, MBA

Managing Director of Life Sciences, Accenture

Technology Advisory Board

Tom Lounibos

Global Managing Director, Accenture Ventures

Business Advisory Board

Ted Love, MD

Former CEO, Global Blood Therapeutics

Business Advisory Board

Ashish Vaswani, PhD

CEO, Essential AI

Technology Advisory Board

Suresh Poda, PhD

VP of Neuroscience & Preclinical Research, Encoded Therapeutics

Scientific Advisory Board

Unlock The Potential of AI
in Drug Discovery

Partner with us

Partner with us

Fill out the form to explore how we can work together.

Company

First Name

Last Name

Email

Phone

Message

Submit Message

Submit Message

Company

First Name

Last Name

Email

Phone

Message

Sumbit Message

Sumbit Message

Oops! Something went wrong while submitting the form.

Message sent successfully

Thanks for reaching out. Our team has received your message and will be in touch shortly.

Or if you prefer, you can contact us directly at

bd@1910.ai

Copy to clipboard

-1:43